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ABSTRACT Ceramides are known to have a regulatory function in apoptosis, including the release of cytochrome c and other
proapoptotic factors from the mitochondrial intermembrane space. Ceramides can form large, stable channels in the outer
mitochondrial membrane, leading to the proposal that ceramide channels are the pathway through which these proteins are
released. Here, we report that sphingosine, a product of ceramide hydrolysis by ceramidase, is capable of destabilizing cer-
amide channels, leading to their disassembly. Sphingosine is directly responsible for the disassembly of ceramide channels in
planar membrane experiments and markedly reduces the ability of ceramide to induce the release of intermembrane space
proteins from mitochondria in vitro. Low concentrations of both L and D sphingosine potentiate the release of intermembrane
space proteins by long-chain ceramide and channel formation in liposomes. These results provide evidence for a mechanism by
which the disassembly of ceramide channels, as initiated by ceramidase, could be accelerated by the direct interaction of the
hydrolysis product with the ceramide channels themselves. This mechanism therefore could form a positive feedback loop for
rapid shut-down of ceramide channels. However, potentiation of ceramide channel formation is also possible and thus both
effects could inﬂuence the propensity for mitochondria-mediated apoptosis.
INTRODUCTION
Apoptosis, or programmed cell death, plays an important role
in the development of multi-cellular organisms and the re-
sponse to cellular damage. The mitochondrion is known to
act as a major hub for the regulation of apoptosis. The key
event of this mitochondrial pathway is the efﬂux of apoptosis-
inducing intermembrane space proteins such as cytochrome
c into the cytoplasm. The release of these proteins leads to the
activation of the caspases that carry out the execution phase
of apoptosis (1,2).
A number of mechanisms have been proposed for the
protein permeation pathway. Candidates for the composition
of this pore include Bax oligomers (3–5), the mitochondrial
apoptosis-induced channel MAC (6), lipidic pores induced
by Bax (7), lipidic pores induced by BH3/Bax/lipid inter-
actions (8,9), and ceramide channels (10–12).
Ceramide has been known, for a long time, to induce apo-
ptosis (13). The addition of ceramide to isolated mitochondria
results in the release of cytochrome c, apoptosis-inducing fac-
tor AIF, AK-2, and adenylate kinase (11,14–17). Both the
short-chainmodel compound,N-acetyl-D-erythro-sphingosine
(C2-ceramide), and a typical naturally occurring long-chain
ceramide, N-hexanoyl-D-erythro-sphingosine (C16-ceramide),
release these proteins. The mechanism of this release is most
likely the formation of large channels in the mitochondrial
outermembrane (MOM)since awhole rangeof intermembrane
space proteins are released up to a molecular mass cutoff of
;60 kDa (11). The exact nature of these large channels is
unknown but the same ceramides form large channels.10 nm
in diameter in phospholipids membranes lacking any proteins
demonstrating that these lipids are sufﬁcient, but other compo-
nents are likely to be involved. The properties of ceramide
channels are consistent with a barrel-stave structure (10,12).
Bolstering the conclusion that channels formed in theMOM
are composed of ceramide molecules as opposed to ceramide
merely acting as a trigger for the formation of another pore
was the observation that the impermeability of the MOM to
proteins could be restored by removing ceramide. Fatty-acid-
depleted albumin effectively reversed the permeabilization of
the MOM by short-chain ceramide. Albumin binds this form
of ceramide and thus the reversal indicates a dynamic equi-
librium between ceramides in the channel with the rest of the
ceramide in the membrane and, when ceramide is removed by
binding to the albumin, the channels disassemble (11). The
fact that the same result was not achieved with C16-ceramide
is understandable due to the exceedingly low aqueous solu-
bility of long-chain ceramide. In many respects, C2-ceramide
and C16-ceramide behave similarly. For example, the perme-
abilization of the MOM was remarkably similar whether
C2-ceramide or C16-ceramide was used in the experiment (11).
One evidence of physiological relevance is the ﬁnding that
ceramide levels become elevated early in the apoptotic pro-
cess. The mitochondrial concentration of ceramide is known
to increase in response to apoptosis-inducing stimuli (18–20).
A typical level at the early stages is 4 pmol ceramide/nmole
phospholipids. At this molar ratio, ceramide effectively per-
meabilizes the outer membrane to cytochrome c (21). Finally,
the enzymes catalyzing the metabolic pathways leading to
both ceramide synthesis and breakdown are known to be pres-
ent in mitochondria (22–24). Taken together, these facts
indicate that the ceramide channel is the permeability pathway
through the mitochondrial outer membrane for protein ﬂux.
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The structurally related lipid, sphingosine, has also been
shown to induce apoptosis (25–30). Although sphingosine
does have the ability to form channels, it was found that these
channels are not sufﬁciently large to allow the passage of in-
termembrane space proteins and that sphingosine itself may
not induce apoptosis by permeabilizing the outer membrane
to proteins (31). Experiments with whole cells indicate that
sphingosine induces apoptosis by acting on speciﬁc proteins
(32). Nevertheless, addition of sphingosine to mitochondria
results in rapid conversion to ceramide (24,31). Interestingly,
Siskind et al. (31) also noted that the ability of ceramide,
generated from added sphingosine, to cause the release of
cytochrome c was less than when the same quantities of cer-
amide were introduced into the mitochondrial membranes by
direct addition of ceramide to the medium (no exogenous
sphingosine). This observation suggested that sphingosine
destabilizes ceramide channels. If this were true, it would
provide evidence for a regulatory pathway in which sphin-
gosine, a product of ceramide hydrolysis by ceramidase, feeds
back to accelerate the closure of ceramide channels by directly
destabilizing them. The experiments described in this work
demonstrate that sphingosine is capable of directly disassem-
bling ceramide channels suggesting the existence of this novel
anti-apoptotic regulatory step.
MATERIALS AND METHODS
Electrophysiological recordings
Planar phospholipid membranes were produced by the monolayer method
(33) as modiﬁed (34), across a 100-mm-diameter hole in a Saran partition.
Monolayers were produced using a solution of 0.5% w/v asolectin, 0.5%w/v
DiPhyPC, 0.1% w/v cholesterol in hexane. This technique produces solvent-
free phospholipids membranes whose lipid composition (focusing on the
polar head-groups) is similar to that found in the mitochondrial outer mem-
brane. It differs from the natural membrane in lacking proteins.
The aqueous solutions contained 1 mM MgCl2, and 5 mM Pipes pH 6.8
with KCl varying from 0.10 M to 1.0 M. The KCl concentration on one side
of the membrane, referred to as the trans side, was always 0.10 M, whereas
the other side the cis side was adjusted as needed. The transmembrane volt-
age was electronically clamped and the current through the membrane was
recorded. The voltage values indicated are the voltage differences across the
membrane cis side minus trans side.
C2-ceramide was stirred into the aqueous solution on each side of the mem-
brane from a solution in DMSO, generally 0.5 mg/ml. Single or multiple
additions, typically 20 ml each, yielding a ﬁnal concentration of 2 mg/ml,
were made to achieve a desired level of conductance. Sphingosine additions
of 5 ml were made from a solution in DMSO (4 mg/mL) yielding a ﬁnal
concentration of 4 mg/mL.
Adenylate kinase release assay
Rat liver mitochondria were isolated by differential centrifugation of tissue
homogenate as described previously (35). The preparation yielded a mito-
chondrial suspension containing ;10 mg of protein per mL. 20 ml of mito-
chondrial suspension were diluted into 1.2 ml of 70 mM sucrose, 210 mM
mannitol, 0.1 mM EGTA, 1 mM Tris-HCl, pH 7.4 yielding a ﬁnal protein
conc. of 0.15 mg/mL. The mitochondria were incubated for 10 min at room
temperature with varying amounts of ceramide added from a 4mg/ml DMSO
solution to determine the amount of ceramide that resulted in ;50% release
of adenylate kinase. The mitochondria were then pelleted at 14,000g for
5 min at 4 C and the supernatant was kept on ice until assayed. 100 ml of
supernatant was added to 700 ml of adenylate kinase reaction mixture:
50 mM Tris-HCl, pH 7.5, 5 mM MgSO4, 10 mM glucose, 5 mM ADP,
0.2 mMNADP, 10 units of hexokinase, and 10 units of glucose-6-phosphate
dehydrogenase (36). The enzymes were added to the rest of the reaction
mixture 1 min before the addition of the mitochondrial supernatant to allow a
trace of ATP to be consumed. The activity of adenylate kinase was detected
as an increase in absorbance at 340 nm. Since the activity of the kinase
decays with time, even on ice, experiments were performed in sets and the
activity of the ﬁrst supernatant was assayed again at the end of the set. The
values were ﬁtted to a ﬁrst order decay and all values within the set were
corrected for the decay of the activity, based on the time delay before assay.
To determine the effect of sphingosine pretreatment on ceramide perme-
abilization of the mitochondrial outer membrane, mitochondria were in-
cubated at room temperature in the presence of varying concentrations of
sphingosine for 5 min before addition of ceramide and incubation for 10 min.
Untreated mitochondria and mitochondria hypotonically lysed (20 ml into
1.2 ml water) served as negative and positive controls, respectively.
Experiments with C16-ceramide were performed in a similar way except
as follows. The mitochondria were suspended in the above medium except
that the 1 mM Tris buffer was replaced by 5 mM HEPES. To 1.0 mL of this
medium at room temperature (RT) was added 17 mL of mitochondrial sus-
pension that had been kept on ice at a concentration of;4 mg/mL. The ﬁnal
mitochondrial protein concentration during the experiment was;80 mg/mL.
In the case of shocked mitochondria, the 1.0 mL of medium was replaced
by water. Sphingosine was added, where appropriate, from a 0.25 mg/mL
solution in DMSO. Typically 4–7 incubations were run in parallel. All
samples were incubated for 5 min at RT. Then some received 0.4 mL of fatty
acid depleted bovine serum albumin (BSA), 25 mg/mL, followed immedi-
ately by 20 mL of C16-ceramide dissolved in isopropanol at 2 mg/mL. After a
10-min incubation at RT, 10 mL of 4 mM PMSF was added followed by
centrifugation. In these experiments 0.3 mL of mitochondrial supernatant
was added to the adenylate kinase reaction mixture.
Liposome experiments
The polar extract of soybean phospholipids (Avanti ½AQ1Polar Lipids, Alabaster,
AL) and cholesterol (Sigma Chemical, St. Louis, MO) were mixed in a 93:7
molar ratio in chloroform and dried under nitrogen followed by drying in
vacuo overnight. This mixture resembles the lipid content of mammalian
mitochondrial outer membranes. Five mg of this mixture was dispersed in
1 mL of 39 mMNaCl, 6 mMDPX (Molecular Probes, Eugene, OR), 1.5 mM
carboxyﬂuorescein (Acros Organics, Geel,Belgium) and subjected to four
freeze-thaw/sonication cycles. After extrusion through a 0.2mmﬁlter (Avanti
Polar Lipids) for 13 passes it was run through a gel ﬁltration column
equilibrated and eluted with 50 mMNaCl, 10 mMHEPES, 1 mMEDTA, pH
7.0. The liposomes were used within 30 h. Twenty-ﬁve microliters of
liposomes were dispersed into 2.0 mL of the elution buffer and placed into a
quartz ﬂuorescence cuvette. The ﬂuorescence was monitored using a Delta-
scan Spectroﬂuorometer (PhotonTechnology Instruments,West Sussex,UK)
using excitation at 495 nm and emission at 520 nm. Forty microliters of
C16-ceramide (2 mg/mL of isopropanol) were added while stirring. Sphin-
gosine was added from either a 1 mg/mL or a 0.1 mg/mL solution in DMSO.
RESULTS AND DISCUSSION
Sphingosine inﬂuences ceramide-dependent
release of adenylate kinase from
isolated mitochondria
Ceramide has been previously shown to increase the perme-
ability of the MOM to small intermembrane space proteins
such as cytochrome c and adenylate kinase (11,14–17).
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Sphingosine has been reported to form channels but these are
small and incapable of allowing proteins to cross membranes
(31). Thus the presence of both ceramide and sphingosine in
a membrane may result in hybrid structures that may or may
not be conductive. The release of adenylate kinase was used
as a measure of MOM permeabilization to small proteins.
To look for interaction between sphingosine and cer-
amide, isolated rat liver mitochondria were treated with
varying levels of sphingosine for 5 min, and then exposed to
ceramide for 10 min at RT. The mitochondria were sedi-
mented and the supernatant assayed for adenylate kinase
activity. The initial rates of these reactions were plotted in
Fig. 1 after normalization for the amount of adenylate kinase
activity released after hypotonic shock. Essentially total inhi-
bition was observed by exposure to 0.3–0.6 mg/mL sphin-
gosine, depending on the batch of isolated mitochondria. In
the concentration range of sphingosine examined (up to 6mg/
mL), sphingosine alone did not induce the release of ade-
nylate kinase (Fig. 1). Thus sphingosine could either desta-
bilize ceramide channels or convert them to much smaller
structures, incapable of allowing the passage of proteins.
These results, obtained with C2-ceramide, differ some-
what from the results obtained with C16-ceramide. As shown
in Fig. 2, the use of C16-ceramide resulted in a biphasic rela-
tionship for the permeabilization of the mitochondrial outer
membrane and release of adenylate kinase. At low concen-
tration, sphingosine potentiated the permeabilization effect
of ceramide whereas at higher concentrations it inhibited the
formation of the ceramide channels, as in the case of
C2-ceramide. Here the actual initial rate of NADPH
production was plotted and the rates observed with vehicle
alone and after hypotonic shock are shown as horizontal
lines.
The potentiation might arise from metabolic conversion
of sphingosine to ceramide by mitochondria. It has been
reported that nearly half of the added sphingosine is con-
verted to ceramide (31), probably by the action of reverse
ceramidase. Thus, the ceramide produced from the sphingo-
sine might combine with the added ceramide to reach a crit-
ical level resulting in channel formation. Excess sphingosine
overwhelms the system resulting in the same inhibition
observed with C2-ceramide.
This hypothesis was tested by determining whether sphin-
gosine converted to ceramide would be capable of perme-
abilizing the MOM to adenylate kinase. Mitochondria were
incubated with 2.4 mg/mL sphingosine for 5 min followed by
addition of 10 mg of fatty acid depleted bovine serum
albumin BSA to remove the unconverted sphingosine. The
release of adenylate kinase is evident in Fig. 3 (S versus SB)
indicating that the removal of excess sphingosine allowed
the ceramide formed to permeabilize the MOM. Note that the
combination of added ceramide and sphingosine converted
to ceramide (SBC. . .after BSA was used to remove excess
sphingosine) resulted in complete release of adenylate kinase.
The long-chain ceramide produced from sphingosine cannot
be removed from the mitochondrial membranes by BSA
addition (11). BSA alone did not result in any release of
adenylate kinase. The addition of BSA to intact mitochon-
dria or mitochondria treated with osmotic shock did not alter
the level of adenylate kinase activity (data not shown)
FIGURE 1 Sphingosine inhibits the ceramide-dependent release of aden-
ylate kinase from mitochondria. Mitochondria were isolated and prepared as
described in Materials and Methods. They were then incubated with the
indicated concentration of sphingosine for 5 min. C2-ceramide was added to
each aliquot (29 mg/mL ﬁnal) and they were incubated for another 10 min.
Note: under these conditions only ;1% of this ceramide inserts into mito-
chondria (21,31). The release of adenylate kinase is expressed as a percent-
age of that released by hypotonic shock. The enzyme activity was recorded
as the initial rate of NADPH production. The experiment was repeated without
the addition of ceramide, and this data is also presented for comparison. The data
shown is one representative example of three independent experiments.
FIGURE 2 Sphingosine inhibits the release of adenylate kinase from
mitochondria induced by C16-ceramide. Adenylate kinase activity was
determined by measuring the initial rate of increase in the level of NADPH
in the medium. Mitochondria were preincubated with the indicated amount
of sphingosine for 5 min. This was followed by the addition of C16-ceramide
to a ﬁnal total concentration of 40 mg/mL. After a 10-min incubation, the
supernatant was assayed for adenylate kinase activity as indicated in
Materials and Methods. The levels of adenylate kinase activity released by
hypotonic shock or after addition of the vehicle alone are indicated as
horizontal lines. This is a typical result of four experiments performed on
different batches of mitochondria.
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showing that BSA does not inﬂuence either adenylate kinase
or the coupled enzyme assay.
An alternative hypothesis for the ability of low levels of
sphingosine to enhance ceramide permeabilization of the
MOM is a direct effect of low-levels of sphingosine on cer-
amide channel stabilization. To test this hypothesis, L-threo
sphingosine was used instead of the natural D-erythro sphin-
gosine. This optical isomer is not metabolized as readily as
the natural isomer. Preincubation with the L-threo sphingo-
sine resulted in the same biphasic effect on ceramide perme-
abilization of the MOM (Fig. 4). Thus the conversion to
ceramide may not be necessary for the potentiating effect of
sphingosine. Conversion was checked by removing excess
L-threo sphingosine with BSA to see if there was a perme-
abilization of the MOM as observed with the same treatment
with the D isomer. In this case, no permeabilization of the
MOM to adenylate kinase was observed. This is consistent
with the conclusion that the D but not the L isomer is con-
verted to ceramide and that both the L and D isomers act to
favor ceramide permeabilization of the MOM when present
at low concentrations.
Sphingosine enhances the ability of ceramide to
permeabilize liposomal membranes
If the ability of low levels of sphingosine to enhance cer-
amide channel formation is a direct action on the channels,
this inﬂuence should also be observed on ceramide channels
formed in liposomes lacking proteins. In these liposomes
there is no possibility of metabolism or indirect effects on
protein factors.
Fig. 5 A shows the ﬂuorescence increase resulting from the
release of carboxyﬂuorescein from liposomes after the addi-
tion of C16-ceramide. Pretreatment with sphingosine causes a
biphasic enhancement of the ceramide-induced permeabili-
zation. At the low doses of sphingosine the formation of
sphingosine channels is sufﬁciently minimal, allowing cer-
amide channel formation to dominate. At the higher doses
the sphingosine-induced carboxyﬂuorescein release is high
enough to mask the expected inhibition of ceramide channel
formation. In any case, the biphasic enhancement is evident
and closely mirrors the results obtained with mitochondria.
The deﬁned nature of the liposome experiments allows one
to conclude that the observed effects of sphingosine on
ceramide channel formation arise from a direct interaction of
sphingosine with the ceramide in the membrane.
The ability of sphingosine to potentiate channel formation
by long-chain ceramide but not by short-chain ceramide may
lie in the fundamental structure of the channel. Molecular
dynamics simulations (37) have provided evidence for dual
curvature in ceramide monomers packed into the channel.
Negative curvature in the plane of the membrane allows for
formation of the annulus. Positive curvature normal to that
plane allows for effective articulation between ceramides and
the phospholipid bilayer. This articulation involves distor-
tion of both ceramides and the phospholipids and would be
ameliorated by the presence of lipids with positive curvature.
Short-chain ceramide already has the low hydrocarbon bulk
that would aid in generating the positive curvature. Perhaps
low concentrations of sphingosine would serve the same
function. At the high concentrations, sphingosine may inter-
calate into the ceramide channels resulting in their destabi-
lization because sphingosine lacks the amide linkage (believed
FIGURE 3 Removal of sphingosine by BSA reverses the inhibition by
sphingosine of C16-ceramide permeabilization of the mitochondrial outer
membrane. The experiments were performed as in Fig. 2. BSA, fatty acid
depleted, was added just before addition of C16-ceramide. The treatments
were as follows: ‘‘shock’’, hypotonic shock only; ‘‘C’’, ceramide added
only 40mg/mL; ‘‘S’’, sphingosine 2.5mg/mL; ‘‘SC’’, sphingosine 2.5mg/mL
followed by C16-ceramide 40 mg/mL; ‘‘SB’’, sphingosine 2.5 mg/mL for 5
min followed by BSA 7 mg/mL; ‘‘SBC’’, sphingosine 2.5 mg/mL for 5 min
followed by BSA 7 mg/mL and C16-ceramide 40 mg/mL; and ‘‘vehicle’’,
instead of ceramide isopropanol was added. See Materials and Methods for
details. The error bars are mean 6 SE of three independent experiments
except for shock n ¼ 7, S n ¼ 5, and SB n ¼ 5. Student’s t-tests showed that
‘‘SC’’ and ‘‘SBC’’ differ at the 99% conﬁdence level; ‘‘S’’ and ‘‘SB’’ at the
99.9% level; ‘‘C’’ and ‘‘SC’’ at the 95% level; and ‘‘C’’ and ‘‘SCB’’ at the
95% level.
FIGURE 4 Experiments were performed as described in Fig. 2 except that
the L isomer of sphingosine was used instead of the naturally occurring D
isomer. ‘‘Untreated’’ refers to the level of adenylate kinase detected in the
supernatant when no reagent was added. Otherwise the mitochondria were
handled in exactly the same way as those treated with sphingosine.
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to be critical to channel stability) and has a net charge that
would lead to electrostatic repulsion.
Sphingosine promotes disassembly of ceramide
channels in planar membranes
The observations of sphingosine induced suppression of
ceramide permeabilization of mitochondrial and liposomal
membranes could have a variety of mechanistic explanations.
The higher levels of sphingosine might prevent the formation
of ceramide channels from monomers (e.g., by forming non-
conducting complexes with these monomers) or sphingosine
might induce the disassembly of ceramide channels. Direct
demonstration of sphingosine-induced ceramide channel dis-
assemblywas achievedbyexperiments onchannel-formation in
planar phospholipids membranes. Ceramide channel conduc-
tance increases in a stepwise fashion, and these conductance
increases have been demonstrated to represent the growth of
a single channel in the membrane (12) as opposed to many
small channels acting in parallel (38). The increases in
conductance in the left half of Fig. 6 are thus increases in the
size of a single channel. The typical ceramide channel grows
in this way over a period of time until it reaches a fairly stable
size. At this point, sphingosine was added (Fig. 6) and the
membrane conductance decreased over the next 15–20 min.
The conductance declined until it reached the level of the
unmodiﬁed membrane, indicating that the ceramide channel
was completely disassembled. Six minutes later, the conduc-
tance increased once again but the nature of this conductance
differed from that of a typical ceramide channel.
The signal observed during the earlier half of this exper-
iment, representing the ﬂow of current through the membrane,
is characteristic of ceramide channels. These characteristics
include the growth of the channel in a steady, stepwise fash-
ion and a relatively high signal/noise. These characteristics
continued through the phase of the experiment during which
the conductance was decreasing, with the channel shrinking
steadily, periodically punctuated with sharp decrements, and
with the current signal showing a low level of noise. In
contrast to this, the increase in conductance that followed
showed no large increments and was highly noisy. The ap-
pearance of this particular type of noise is characteristic of
sphingosine channels (31), reﬂecting the fact that sphingo-
sine forms multiple channels in the planar membrane and
that these channels exist only transiently, thus explaining the
wide ﬂuctuations in the current.
Selectivity change corresponds to transition
from ceramide channel to sphingosine channels
To test the interpretation of Fig. 6, selectivity experiments
were performed to distinguish between ceramide conduc-
tance and sphingosine conductance. Ceramide and sphin-
gosine channels differ in their ion selectivities. Ceramide
FIGURE 5 Sphingosine inﬂuences ceramide channel formation in lipo-
somes in a biphasic fashion. (A) The release of carboxyﬂuorescein from
liposomes by C16-ceramide (80 mg) alone or after the liposomes (90 mg of
lipid) were pretreated with the indicated amounts of sphingosine (see
Materials and Methods). The release is expressed as a fraction of the release
achieved with 0.08% Triton X100. (B) The ﬂuorescence level achieved in
the experiments described in A 100 s after ceramide addition. Results are
representative of two experiments.
FIGURE 6 Changes in conductance demonstrate ceramide channel dis-
assembly. A ceramide channel was allowed to form after the addition of
C2-ceramide (9 mg/mL) to each side of the membrane. Once channel growth
had slowed, sphingosine (4 mg/mL) was added to the cis side of the membrane,
at the time indicated. The ﬁgure shows the continuous recording of conductance
across the membrane. The applied voltage was clamped at 10 mV.
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channels are weakly cation selective (12), and the magnitude
of this selectivity decreases as the channel size conductance
increases. Sphingosine channels, have a preference for an-
ions, likely owing to the positive charge on the sphingosine
molecule (31), and thus they exhibit a positive reversal
potential. Therefore by monitoring the reversal potential one
can distinguish between conductance arising from ceramide
channels and that due to sphingosine channels.
Fig. 7 shows an experiment where both the conductance
and the reversal potential were measured at regular intervals.
The applied voltage was changed in steps allowing the con-
ductance to be measured. The reversal potential was cal-
culated: reversal potential ¼ applied voltage  [current/
conductance]. The ﬁgure begins after the conductance of the
ceramide channel had stabilized and sphingosine was added.
The conductance declined with time reaching a minimum at
;20 min. Then the reversal potential changed rapidly from
negative to positive values indicating a change from cation
to anion selectivity and thus a change from ceramide chan-
nel conductance to the conductance of sphingosine channels.
Note that a further rise in conductance resulted in little change
in reversal potential because the selectivity of sphingosine
channels remained fairly steady irrespective of the number of
channels present or the magnitude of the overall conductance.
The timing of the change of reversal potential corre-
sponded with the point at which the conductance of the
membrane began to increase, as indicated by the dashed lines
in Fig. 7. This behavior is indicative of a changeover in the
primary source of the membrane selectivity from a single
ceramide channel to many sphingosine channels.
Other features of note in the Fig. 7 provide insight into the
process of channel disassembly. One would expect that the
gradual loss of ceramide conductance reﬂects the shrinkage
of the ceramide channel. As the channel becomes smaller the
ion selectivity should increase as previously described (12).
However, as the ceramide conductance declined the reversal
potential of the membrane stayed roughly constant, and
eventually moves toward zero. Therefore, the presence of
sphingosine in the membrane may somehow prevent the
expected selectivity increase. One possibility is that sphin-
gosine channels may have already begun to form in parallel
with the ceramide channel, and that the formation of these
anion selective channels negates and eventually overcomes
the increase in cation selectivity expected from the shrinking
ceramide channel. Another possibility is that some of the
sphingosine incorporates itself into the ceramide channels,
and thus not only destabilizes them, but also changes their
characteristic selectivity by introducing positive charge near
the inner wall of the channel. These two possibilities are,
of course, not mutually exclusive and could be occurring
simultaneously. The dominance of one over the other may
also depend on how much sphingosine was added.
These results demonstrate the ability of sphingosine to
markedly reduce the ceramide-induced permeability of the
outer mitochondrial membrane to intermembrane space pro-
teins. In whole mitochondria this could be due to a variety of
mechanisms but in view of the results obtained in planar
membranes, simple disassembly of ceramide channels is the
simplest explanation.
When experiments performed on mitochondria isolated
from different animals are pooled, the error bars are fairly
large because there is variability of the response from one
mitochondrial preparation to another. However, the changes
were always in the same direction and the reported effects are
statistically signiﬁcant. The relative response under different
conditions also depended on the potency of the ceramide-
induced permeabilization, again this varied from one batch
of mitochondria to another.
The effects described here might be subject to a variety of
criticisms. First of all one might be concerned that sphin-
gosine might form micelles in the medium that would act as
sinks for the ceramide resulting in the trapping of ceramide
and thus inhibition of ceramide channel formation. However,
the published CMC for sphingosine is more than 30 mg/mL
(39), far greater than the amounts used. In addition, by using
FIGURE 7 Changes in reversal potential indicate changes in channel com-
position. A ceramide channel was formed after the addition of C2-ceramide
(3 mg/mL) to each side of the membrane. After channel growth slowed, KCl
was added to the aqueous solution on the cis side of the membrane to a
ﬁnal concentration of 0.45 M. MgCl2 and Pipes concentrations remained
unchanged. The channel-containing membrane was then left undisturbed for
30 min. Sphingosine was added to a ﬁnal concentration of 8 mg/mL at t ¼
0 min. The conductance and reversal potential of the channel was measured
periodically over the following 30 min. This is one of three independent
experiments.
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radiolabeled sphingosine we ﬁnd that more than 80% of
added sphingosine partitions into mitochondria and thus the
amount of sphingosine in the medium is far less than that
indicated in the ﬁgures and text. Thus the possibility of an
artifact from sphingosine micelles is unrealistic. Another
criticism is the amounts of sphingolipids used in these ex-
periments as compared to levels found in cells. Again the use
of radioisotopes shows that most of the ceramide added does
not insert into mitochondria (21). The amount that does
insert is within the physiological range 4 pmoles ceramide
per nmole of phospholipids, the level measured early in apo-
ptosis in mitochondria. The physiological levels of sphin-
gosine in mitochondria during apoptosis are not well deﬁned.
Cellular levels increase to an equivalent of 1.5–3 mg/mL (27)
but the level in the mitochondrial outer membrane is unclear.
However, the action of ceramidase would generate sphin-
gosine and local levels may indeed be high enough to favor
ceramide disassembly. Note that after correcting for differ-
ences in insertion of ceramide and sphingosine, the levels
used here are rather comparable as might be expected in the
mitochondrial membrane when active turnover is occurring.
CONCLUSION
The observed disassembly of ceramide channels in the pre-
sence of sphingosine provides evidence for a potential
ampliﬁcation of the negative regulation of ceramide channels
through the action of ceramidase. This enzyme, found in
mitochondrial membranes, hydrolyzes ceramide to produce
sphingosine (22,24), thus reducing the concentration of cer-
amide in the membrane and leading to channel shrinkage or
disassembly. This disassembly process could be hastened by
the presence of the reaction product, sphingosine, which am-
pliﬁes the effect of the decreasing concentration of ceramide
on the size of the ceramide channel by direct interaction with
the channel to destabilize it. It depends on the local sphin-
gosine level because if the level is too low there is poten-
tiation rather than inhibition. As ceramidase continues to act,
the concentration of sphingosine relative to ceramide con-
tinues to increase, thus accelerating the disassembly process.
This putative self-amplifying regulatory mechanism thus
becomes a candidate for an anti-apoptotic regulatory step.
The potentiating effect of sphingosine at lower concen-
trations may also be physiologically important and is con-
sistent with the reported pro-apoptotic effect of sphingosine.
The local concentration of sphingosine is key to knowing
how sphingosine will act.
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